30 September 2026
HGH Research: 69.6% of Diagnoses Reversed on Retest
A 2026 systematic review retested 2,057 children on HGH. Most no longer met deficiency criteria. What that means for somatropin research in Australia.
Peptides · Growth Hormone Axis
Human Growth Hormone
Somatropin · HGH · rhGH
TGA-approved medicine (Schedule 4)
The benchmark the rest of this space is measured against: recombinant human growth hormone is a fully approved, PBS-subsidised medicine in Australia for defined conditions — and simultaneously one of the most misused compounds in anti-aging and bodybuilding circles.
At a glance
- Decades of evidence for genuine growth hormone deficiency
- PBS-subsidised in Australia under specialist criteria
- Anti-aging trials: modest body-composition change, real side effects
- WADA-prohibited and border-controlled in Australia
How it works
HGH stimulates growth and cell reproduction largely via IGF-1, driving childhood growth and influencing muscle, bone and fat metabolism throughout life. Pharmaceutical somatropin replaces the hormone in people whose pituitary doesn't produce enough.
What the research shows
For approved uses — paediatric and adult growth hormone deficiency, Turner syndrome and other defined conditions — the evidence is extensive and decades deep. For anti-aging in healthy adults, trials show modest body-composition changes with real side effects (fluid retention, joint pain, insulin resistance) and no demonstrated longevity benefit.
Regulatory status
Australia
TGA-approved and PBS-subsidised for specific conditions under specialist criteria. It is Schedule 4 (prescription-only) and a border-controlled import — possession without a prescription is illegal.
Worldwide
Approved by the FDA, EMA and regulators worldwide for defined indications. Prescribing it for anti-aging is unlawful in the US. Prohibited in sport by WADA.
Latest Human Growth Hormone articles
27 September 2026
HGH and Idiopathic Short Stature: The 33 Adult Heights
HGH research for idiopathic short stature rests on one placebo-controlled trial with 33 adult heights and 3.7 cm. Plus the PBS route in Australia.
25 September 2026
Weekly HGH vs Daily Somatropin: The Missing Head-to-Head
Weekly HGH vs daily somatropin: what the 2026 evidence shows, why no head-to-head trial exists, and how the PBS Growth Hormone Program works in Australia.
22 September 2026
HGH Diagnosis: The Test That Gates Somatropin in Australia
A 2026 real-world study shows BMI and cut-off choice change who gets diagnosed with growth hormone deficiency. What that means for HGH in Australia.
16 September 2026
Weekly HGH Research: The 1.7 kg foresiGHt Result
What is weekly HGH? The foresiGHt trial added 1.70 kg lean mass in GH-deficient adults - the same ballpark as anti-ageing trials. Plus HGH Australia rules.
14 September 2026
HGH Blood Test Australia: Why IGF-1 Can't Diagnose You
Human growth hormone in Australia: why a normal IGF-1 blood test doesn't rule out GH deficiency, what stimulation testing shows, and how PBS criteria work.
11 September 2026
Fake HGH Australia: What Lab Testing Found in the Vials
Is HGH legal in Australia? What lab analysis found inside internet-bought somatropin vials, the TGA counterfeit alert, and why cold chain changes the risk.
28 August 2026
HGH Research: The Weekly Injection Shift, Explained
What is HGH, and is HGH legal in Australia? Inside the shift from daily somatropin to weekly growth hormone analogues, and what the trial evidence shows.
27 August 2026
HGH in Australia: Approved Uses, PBS Rules and the Hype
HGH is the rare peptide that is an approved medicine. What the TGA approves, what the PBS covers, the anti-aging evidence, and Australia's legal lines.
This is general information, not medical advice. retatrutide.net.au is an independent publication. Unless stated otherwise above, this compound is not an approved medicine in Australia, and this page does not endorse or facilitate its use. Speak to a registered health practitioner about any treatment decision.
Stay informed
Be first to know.
When it reaches Australia.
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
- The latest clinical trial results and news from Eli Lilly
- Updates on TGA regulatory progress in Australia
- How and where to access Retatrutide when it becomes available
- Occasional information from retatrutide.net.au and our affiliated partners
TGA review expected 2027 — subscribers hear the moment the status changes.
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.